EU Rare Disease Policy Needs To Help Revive Abandoned Candidates & Repurpose Existing Drugs

 
• By Eliza Slawther

The EU must adopt a more comprehensive policy on rare diseases to increase the number of orphan drugs and address access challenges, says EURORDIS’ chief executive Yann Le Cam.

Abandoned house
Sponsors could revisit abandoned orphan drug candidates • Source: Shutterstock

More from Health Technology Assessment

More from Market Access